Corporate Finance

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

The investment firm renews its plan to repurchase up to 5% of its units, signaling a strong belief that its market price is below its intrinsic value.

Amidst legal industry fears of generative AI, BriefCatch's $6M funding and stellar retention prove the value of a trusted, specialized AI writing partner.

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

Emmaus Life Sciences outsources its sickle cell drug Endari® in North America to focus on global growth, as NeoImmuneTech gains a key U.S. market foothold.

KORU Medical seeks FDA clearance for its FreedomEDGE® system with a key breast cancer drug, signaling a major shift in cancer care delivery.

Amid market volatility and a green energy push, Devon's CEO will outline the firm's strategy for navigating a complex 2026 at a top industry event.

In a strategic move signaling confidence in American nuclear energy, IsoEnergy has significantly increased its ownership in Premier American Uranium.

PacBio heads to J.P. Morgan's conference with new tech aimed at making long-read sequencing cheaper. Can it challenge rivals and win over investors?

SOLAI shareholders approved a massive 30 billion share increase, arming the firm for a radical pivot into AI and the Solana ecosystem. But what about dilution?

Realty ONE Group predicts a major 2026 real estate comeback. We dig into the data, expert opinions, and the strategy behind this bold forecast.

Amid economic headwinds, the M&A advisor thrived by securing over 90 deals and promoting key partners, signaling strong momentum for healthcare sales in 2026.

As data centers face an energy crisis fueled by AI, Aradatum is commercializing a unique vertical wind turbine promising a dense, low-cost power solution.

Fresh off a successful IPO, Ceribell is set to showcase its revolutionary AI-powered EEG system, a device already changing outcomes in ICUs nationwide.

As 'GLP-1 patch' ads flood social media for New Year's, an investigation reveals misleading marketing, a lack of science, and complex global companies.

Drivers and businesses face a new financial landscape as the IRS raises the mileage rate, reflecting the high cost of vehicle ownership beyond the pump.

Veracyte prepares for the J.P. Morgan conference, where it will showcase its AI and genomic strategy amid strong financials and a competitive market.

The popular brunch chain is betting on a digital marketing guru to transform its customer experience and accelerate growth in a tech-driven market.

After 16 years, Chief Legal Officer Anthony Green announces his retirement, leaving a void at the top and questions about Annaly's future governance.

Facing stock pressure, Dot Ai bets on seasoned sales leader Delores Rochester to scale its enterprise business in the booming Asset Intelligence market.